Onkologie. 2025:19(1):42-45 | DOI: 10.36290/xon.2025.010

Pleomorphic dermal sarcoma

Vladimír Bartoš1, Dagmar Hurtová2
1 Martinské bioptické centrum, s. r. o., Martin, Slovenská republika
2 Dermatovenerologická ambulancia, Púchov, Slovenská republika

Introduction: Pleomorphic dermal sarcoma (PDS) is a rare malignant mesenchymal tumor of the skin. It clinically and histogenetically shares similar features with atypical fibroxanthoma (AFX) and they are thought to represent the morphologic spectrum of one neoplasia.

Case report: A 60-year-old man with a history of vocal cord carcinoma had observed an ulcerated skin tumor in the scalp growing for several months. It was removed by surgical excision. Histology revealed a solid mesenchymal tumor consisting of atypical cells population of epithelioid and histiocytoid appearance. At the base, it infiltrated the subcutaneous fat and extended into the deep fascia. A blood vessel filled with a tumor thrombus was found. The tumor was positive for CD68, CD10, CD163, CD99 and partly reactive for αSMA and CD31. The diagnosis of PDS was established. The patient underwent PET/CT examination with a negative result. The cervical lymph nodes were not enlarged. A wide re-excision of the scar region was performed without evidence of residual tumor. The patient continues to be monitored, currently without signs of recurrence.

Conclusion: PDS represents a diagnostic challenge for pathologists. It mostly occurs in old men in the capillitium and in this location, which is typical for non-melanoma skin cancer, represents an important differential diagnosis. Its differentiation from the histogenetically and structurally related but clinically much more favorable AFX can be very difficult, but essential in terms of further prognosis and clinical management of the patient.

Keywords: pleomorphic dermal sarcoma, atypical fibroxanthoma, cutaneous sarcomas.

Accepted: February 27, 2025; Published: March 10, 2025  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Bartoš V, Hurtová D. Pleomorphic dermal sarcoma. Onkologie. 2025;19(1):42-45. doi: 10.36290/xon.2025.010.
Download citation

References

  1. Brenn T, Wick MR. Pleomorpic dermal sarcoma. In: Elder DE, Massi D, Scolyer RA, Willemze R. WHO Classification of Skin Tumours. 4th Edition. IARC: Lyon; 2018; 370-371.
  2. Mahmood MN. Histopathologic evaluation of atypical fibroxanthoma or pleomorphic dermal sarcoma debulk specimen from Mohs surgery: a requirement for their proper distinction. Dermatopathology. 2024;11(3):184-191. Go to original source... Go to PubMed...
  3. Ríos-Viñuela E, Serra-Guillén C, Llombart B, et al. Pleomorphic dermal sarcoma: a retrospective study of 16 cases in a dermato-oncology centre and a review of the literature. Eur J Dermatol. 2020;30(5):545-553. Go to original source... Go to PubMed...
  4. Helbig D, Ziemer M, Dippel E, et al. S1-guideline atypical fibroxanthoma (AFX) and pleomorphic dermal sarcoma (PDS). J Dtsch Dermatol Ges. 2022;20(2):235-243. Go to original source... Go to PubMed...
  5. Kuntz T, Siebdrath J, Hofmann SC, et al. Increase of atypical fibroxanthoma and pleomorphic dermal sarcoma: a retrospective analysis of four German skin cancer centers. J Dtsch Dermatol Ges. 2022;20(12):1581-1588. Go to original source... Go to PubMed...
  6. Llombart B, Serra-Guillén C, Requena C, et al. Leiomyosarcoma and pleomorphic dermal sarcoma: Guidelines for diagnosis and treatment. Actas Dermosifiliogr (Engl Ed). 2019;110(1):4-11. Go to original source... Go to PubMed...
  7. Bartoš V. Svetlobunkový variant atypického fibroxantómu u pacienta s viacpočetnými keratinocytovými karcinómami kože. Onkologie. 2024;18(1):74-77. Go to original source...
  8. Persa OD, Loquai C, Wobser M, et al. Extended surgical safety margins and ulceration are associated with an improved prognosis in pleomorphic dermal sarcomas. J Eur Acad Dermatol Venereol. 2019;33(8):1577-1580. Go to original source... Go to PubMed...
  9. Ørholt M, Abebe K, Rasmussen LE, et al. Atypical fibroxanthoma and pleomorphic dermal sarcoma: Local recurrence and metastasis in a nationwide population-based cohort of 1118 patients. J Am Acad Dermatol. 2023;89(6):1177-1184. Go to original source... Go to PubMed...
  10. Miller K, Goodlad JR, Brenn T. Pleomorphic dermal sarcoma: adverse histologic features predict aggressive behavior and allow distinction from atypical fibroxanthoma. Am J Surg Pathol. 2012;36(9):1317-1326. Go to original source... Go to PubMed...
  11. Tardio JC, Pinedo F, Aramburu JA, et al. Pleomorphic dermal sarcoma: a more aggressive neoplasm than previously estimated. J Cutan Pathol. 2016;43(2):101-112. Go to original source... Go to PubMed...




Oncology

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.